Related Experiment Videos
Enhancement of the 5-HT neurotransmission by antidepressant treatments
Abstract:
The hypothesis of an etiopathogenic role of 5-HT and that of a mediation by the 5-HT system in the effect of antidepressant treatments have often been confused. Little unequivocal evidence exists for a 5-HT deficit in depression. However, several recent animal and clinical data suggest that the 5-HT system might contribute to the therapeutic effect of various antidepressant treatments. Long-term administration of tricyclic antidepressant (TCA) drugs induces a sensitization of rat forebrain neurons to iontophoretically-applied 5-HT. Repeated electroconvulsive shocks result also in an increased sensitivity of forebrain 5-HT receptors. However, chronic administration of a new antidepressant drug, zimelidine, a potent and long-lasting 5-HT uptake blocker, fails to modify 5-HT receptor sensitivity. These results suggest that enhancement of 5-HT neurotransmission obtained via either pre- or postsynaptic mechanisms might determine the antidepressant effect of these treatments. In a recent clinical study, we observed that lithium administration to TCA-resistant depressive patients induced a rapid relief of depression. It is possible that the presynaptic enhancing effect of lithium on the 5-HT system might unveil the TCA-induced sensitization of the postsynaptic 5-HT receptors. Most depressed patients exhibit marked diurnal variations of mood. Preliminary experiments in rats revealed that the responsiveness of hippocampal neurons to iontophoretically-applied 5-HT is enhanced in the evening. Similar diurnal variations of 5-HT receptor sensitivity might occur in human brain and be related to diurnal variation of mood in depression. Since normal individuals do not show these fluctuations of mood, it is proposed that the "mood regulating system" might become 5-HT dependent in depressed patients.
Insights
The 5-HT system
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- The role of serotonin (5-HT) in depression and antidepressant treatment efficacy is complex and often conflated.
- Limited evidence supports a direct 5-HT deficit in depression, but the 5-HT system's involvement in treatment effects is increasingly suggested.
- Tricyclic antidepressants (TCAs) and electroconvulsive shocks sensitize forebrain 5-HT receptors in rats, while zimelidine does not.
Purpose of the Study:
- To investigate the role of the serotonin (5-HT) system in antidepressant treatment mechanisms.
- To explore the potential of enhancing 5-HT neurotransmission for therapeutic effects.
- To examine the influence of lithium and diurnal variations on 5-HT receptor sensitivity in depression.
Main Methods:
- Administering tricyclic antidepressant (TCA) drugs and electroconvulsive shocks to rats to assess 5-HT receptor sensitivity.
- Chronic administration of zimelidine, a 5-HT uptake blocker, in rats.
- Clinical study involving lithium administration to TCA-resistant depressive patients.
- Electrophysiological experiments in rats to measure hippocampal neuronal responsiveness to 5-HT.
Main Results:
- Long-term TCA administration and electroconvulsive shocks increased forebrain 5-HT receptor sensitivity in rats.
- Zimelidine did not alter 5-HT receptor sensitivity.
- Lithium rapidly relieved depression in TCA-resistant patients, potentially by enhancing presynaptic 5-HT effects.
- Rat hippocampal neurons showed enhanced 5-HT responsiveness in the evening, suggesting potential diurnal variations.
Conclusions:
- Enhancement of 5-HT neurotransmission, via pre- or postsynaptic mechanisms, may underlie antidepressant treatment efficacy.
- Lithium's presynaptic action might facilitate TCA-induced postsynaptic 5-HT receptor sensitization.
- Diurnal variations in 5-HT receptor sensitivity could be linked to mood fluctuations in depression, suggesting a 5-HT-dependent mood regulation system in depressed patients.